Press Release July 6, 2021Goldman Sachs Asset Management and NAIC Partnership Expands Opportunities for Diverse Alternative Investment Managers 0 0 Share
Press Release July 6, 2021Provention Bio Receives Complete Response Letter (CRL) to Biologics License Application (BLA) for Teplizumab for the Delay of Clinical Type 1 Diabetes (T1D) in At-risk Individuals 0 0 Share
Company Ticker News July 6, 2021Agenus says its Bristol Myers Squibb licensing deal has up to $1.3 billion in milestone payments 0 0 Share
Video News July 6, 2021Pentagon cancels $10 billion JEDI contract at center of Microsoft-Amazon fight 0 0 Share
Company Ticker News July 6, 2021Charter to Hold Conference Call to Discuss Second Quarter 2021 Financial and Operating Results 0 0 Share
Press Release July 6, 2021INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Frequency Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 0 0 Share
General Market News July 6, 2021Futures mixed as U.S.-listed Chinese firms drop on regulation worries 0 0 Share
Press Release July 6, 2021Agenus Closes $200M Upfront BMS Collaboration and Announces FDA Acceptance of IND for Partnered Anti-TIGIT Bispecific Antibody, AGEN1777 0 0 Share